Restricted accessResearch articleFirst published online 2025
Analysis of safety,efficacy,and risk factors for poor clinical prognosis of dual antiplatelet therapy after stent-assisted coil embolization for intracranial ruptured aneurysms
Dual antiplatelet therapy (DAPT) following stent-assisted coil (SAC) embolization increases the risk of ischemic and hemorrhagic complications. To evaluate the safety and efficacy of DAPT in treating acute ruptured aneurysms after SAC and analyze risk factors for poor clinical prognosis.
Methods
We retrospectively analyzed data from patients with aneurysmal subarachnoid hemorrhage (aSAH) between 1 May 2017 and 31 December 2021. Patients were divided into the SAC group and the non-SAC group (NSC). The SAC group received DAPT. We also compared modified Rankin Scale scores and the incidence of bleeding and ischemic complications. Additionally, we analyzed risk factors affecting clinical prognosis.
Results
A total of 2612 patients were included in the analysis: 1011 in the SAC group and 1601 in the NSC group. During hospitalization, there was no significant difference in bleeding and ischemic complications between the groups. Similarly, there was no statistically significant difference in clinical prognosis between the SAC and NSC groups at discharge and six months after discharge. Multivariate analysis indicated age, previous cerebral hemorrhage, posterior circulation aneurysm, multiple aneurysms, modified Fisher scale 3–4, and Glasgow Coma Scale (GCS) scores of 3–8 and 9–12 as risk factors for poor clinical prognosis after SAC.
Conclusions
DAPT after SAC for intracranial ruptured aneurysms was found to be safe and effective. Age, previous cerebral hemorrhage, posterior circulation aneurysm, multiple aneurysms, modified Fisher scale 3–4, and GCS scores of 3–12 were identified as risk factors for poor prognosis.
HughesJDBondKMMekaryRA, et al.Estimating the global incidence of aneurysmal subarachnoid hemorrhage: a systematic review for central nervous system vascular lesions and meta-analysis of ruptured aneurysms. World Neurosurg2018; 115: 430–447.e7.
4.
RegusSLangW. Rupture risk and etiology of visceral artery aneurysms and pseudoaneurysms: a single-center experience. Vasc Endovascular Surg2016; 50: 10–15.
5.
ChalouhiNJabbourPSinghalS, et al.Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke2013; 44: 1348–1353.
6.
IslimFISaleemNPatankarT. A review and journey in intrasaccular treatment of intracranial aneurysms. Interv Neuroradiol2023: 15910199231182460.
7.
HenkesHBoseAFelberS, et al.Endovascular coil occlusion of intracranial aneurysms assisted by a novel self-expandable nitinol microstent (neuroform). Interv Neuroradiol2002; 8: 107–119.
8.
InvestigatorsSBenaventeORHartRG, et al.Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med2012; 367: 817–825.
9.
MaADetaramHDSteinfortB, et al.Antiplatelet therapy in neurointervention. Semin Neurol2023; 43: 466–479.
10.
NagahamaYAllanLNakagawaD, et al.Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. J Neurosurg2018; 129: 702–710.
11.
ZuoQYangPLvN, et al.Safety of coiling with stent placement for the treatment of ruptured wide-necked intracranial aneurysms: a contemporary cohort study in a high-volume center after improvement of skills and strategy. J Neurosurg2019; 131: 435–441.
12.
HohBLKoNUAmin-HanjaniS, et al.2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke2023; 54: e314–e370.
13.
SaniSJobeKWLopesDK. Treatment of wide-necked cerebral aneurysms with the Neuroform2 Treo stent. A prospective 6-month study. Neurosurg Focus2005; 18: E4.
14.
GeyikSYavuzKYurttutanN, et al.Stent-assisted coiling in endovascular treatment of 500 consecutive cerebral aneurysms with long-term follow-up. American Journal of Neuroradiology2013; 34: 2157–2162.
15.
FisherMKnappertzV. Comments in response to “analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials”. Am J Cardiol2005; 96: 1467.
16.
ErginaPLCookJABlazebyJM, et al.Challenges in evaluating surgical innovation. Lancet (London, England)2009; 374: 1097–1104.
17.
BechanRSSprengersMEMajoieCB, et al.Stent-assisted coil embolization of intracranial aneurysms: complications in acutely ruptured versus unruptured aneurysms. Am J Neuroradiol2016; 37: 502–507.
18.
LiangGGaoXLiZ, et al.Neuroform stent-assisted coiling of intracranial aneurysms: a 5 year single-center experience and follow-up. Neurol Res2010; 32: 721–727.
19.
RyuC-WParkSShinHS, et al.Complications in stent-assisted endovascular therapy of ruptured intracranial aneurysms and relevance to antiplatelet administration: a systematic review. Am J Neuroradiol2015; 36: 1682–1688.
20.
ChungJLimYCSuhSH, et al.Stent-assisted coil embolization of ruptured wide-necked aneurysms in the acute period: incidence of and risk factors for periprocedural complications. J Neurosurg2014; 121: 4–11.
21.
RohHKimJBaeH, et al.Comparison of stent-assisted and no-stent coil embolization for safety and effectiveness in the treatment of ruptured intracranial aneurysms. J Neurosurg2020; 133: 814–820.
22.
HeyeSStrackeCPNordmeyerH, et al.Retrograde access to the posterior inferior cerebellar artery in balloon-assisted coiling of posterior inferior cerebellar artery aneurysms. J Neurointerv Surg2015; 7: 824–828.
23.
ListerJRRhotonALMatsushimaT, et al.Microsurgical anatomy of the posterior inferior cerebellar artery. Neurosurgery1982; 10: 170–199.
24.
ForgetTRBenitezRVeznedarogluE, et al.A review of size and location of ruptured intracranial aneurysms. Neurosurgery2001; 49: 1322–1325; discussion 1325-6.
25.
MutoMGiurazzaFAmbrosanioG, et al.Stent-assisted coiling in ruptured cerebral aneurysms: multi-center experience in acute phase. Radiol Med2017; 122: 43–52.
26.
WangSZhangTDuL, et al.Safety and efficacy of dual antiplatelet drugs for stent-assisted embolization on risk of stroke and prognosis in patients with ruptured intracranial aneurysms: one center results of CIAP-5 clinical trial. Interv Neuroradiol2024: 15910199231219212.
27.
MehtaRTraineeGChinthapalliK, et al.Glasgow Coma Scale explained. BMJ (Clin Res ed)2019; 365: l1296.
28.
JuvelaSKorjaM. Intracranial aneurysm parameters for predicting a future subarachnoid hemorrhage: a long-term follow-up study. Neurosurgery2017; 81: 432–440.
29.
ZhaoBYangHZhengK, et al.Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage. J Neurosurg2017; 126: 1764–1771.
30.
CaiJXuDBaiX, et al.Curcumin mitigates cerebral vasospasm and early brain injury following subarachnoid hemorrhage via inhibiting cerebral inflammation. Brain Behav2017; 7: e00790.
31.
HaoGShiZHuanY, et al.Construction and verification of risk predicting models to evaluate the possibility of hydrocephalus following aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis2024; 33: 107535.
32.
YoshidaRTakagiKMorishimaI, et al.Coil embolization of pseudoaneurysm as a complication of excimer laser coronary angioplasty: insights from intravascular ultrasound and optical coherence tomography findings. J Med Ultrason2019; 46: 245–249.
33.
RyttleforsMEnbladPKerrRSC, et al.International subarachnoid aneurysm trial of neurosurgical clipping versus endovascular coiling: subgroup analysis of 278 elderly patients. Stroke2008; 39: 2720–2726.
34.
DuanGYangPLiQ, et al.Prognosis predicting score for endovascular treatment of aneurysmal subarachnoid hemorrhage: a risk modeling study for individual elderly patients. Medicine (Baltimore)2016; 95: e2686.
35.
JajaBNRLingsmaHSteyerbergEW, et al.Neuroimaging characteristics of ruptured aneurysm as predictors of outcome after aneurysmal subarachnoid hemorrhage: pooled analyses of the SAHIT cohort. J Neurosurg2016; 124: 1703–1711.
36.
HuangQ-YHuangQLinS-W, et al.Prognostic factors affecting the ruptured intracranial aneurysms: a 9-year multicenter study in Fujian, China. Medicine (Baltimore)2023; 102: e34893.
37.
MolyneuxAJKerrRSCYuL-M, et al.International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet (London, England)2005; 366: 809–817.
38.
MolyneuxAJKerrRSCBirksJ, et al.Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol2009; 8: 427–433.
